Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | PBR.A | XOM |
|---|---|---|
| Price | $19.07 | $162.51 |
| Change today | ▼ 0.81% | ▲ 0.79% |
| Market cap | $122.86B | $668.23B |
| Return, 3 months | +33.6% | +19.5% |
| Return, year to date | +80.1% | +37.8% |
| Return, 1 year | +71.1% | +46.0% |
| P/E (TTM) | 4.8 | 20.9 |
| P/B | 1.3 | 2.6 |
| P/E percentile vs own 5y | 60th | 90th |
| Dividend yield | 6.01% | 2.51% |
| Revenue growth (YoY, latest qtr) | +59.8% | +44.1% |
| Net profit growth (YoY) | +119.4% | +102.4% |
| Gross margin | 50.7% | 20.6% |
| Operating margin | 35.3% | 10.7% |
| Net margin | 24.5% | 9.1% |
| Return on equity | 30.8% | 12.6% |
| Analyst target vs. price | – | +4.7% |
| Analyst buy share | – | 50% |
| RSI (14) | 67 | 51 |
| 30-day volatility | 30.3% | 25.7% |
| Max drawdown, 1 year | -26.0% | -20.1% |
| Trend read | Strong uptrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.